Digest Network Come funziona
Network
/
Società
De
Non verificato

Definium Therapeutics, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VariePsichiatriaSalute

33 comunicati stampa

Guarda tutti i comunicati
20/07/2026
Mercato del lavoro
Finanza
Medicina alternativa
Psichiatria
Salute
Farmaceutica
Biotecnologia
Definium Therapeutics Announces New Employee Inducement Grants
Fonte
Definium Therapeutics, Inc.
Emittente
Business Wire
1.00
0
16/07/2026
Definium Therapeutics Launches Wired for Worry, a Health Care Provider Initiative to Advance the Understanding of Generalized Anxiety Disorder (GAD) Patient Impact and Neurobiology
Fonte
Definium Therapeutics, Inc.
Emittente
Business Wire
1.00
0
14/07/2026
Scienza
Farmaceutica
Medicina alternativa
Sanità
Salute
Psichiatria
Analisi di mercato
Industria
New Healthcare Claims Study Published in CNS Spectrums Finds High Rates of Treatment Switching, Discontinuation, and Prolonged Gaps in Care Among Patients with Generalized Anxiety Disorder (GAD)
Fonte
Definium Therapeutics, Inc.
Emittente
Business Wire
1.00
0
06/07/2026
Mercato azionario
Psichiatria
Scienza
Biotecnologia
Medicina alternativa
Salute
Farmaceutica
Definium Therapeutics Announces New Employee Inducement Grants
Fonte
Definium Therapeutics, Inc.
Emittente
Business Wire
1.00
0
25/06/2026
Finanza
Scienza
Biotecnologia
Farmaceutica
Medicina alternativa
Salute
Psichiatria
Definium Therapeutics, Inc. Announces Closing of $805 Million Upsized Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Fonte
Definium Therapeutics, Inc.
Emittente
Business Wire
1.00
0
24/06/2026
Finanza
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Definium Therapeutics, Inc. Announces Pricing of $700 Million Upsized Public Offering
Fonte
Definium Therapeutics, Inc.
Emittente
Business Wire
1.00
0
22/06/2026
Finanza
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Definium Therapeutics, Inc. Announces Proposed Public Offering
Fonte
Definium Therapeutics, Inc.
Emittente
Business Wire
1.00
0
22/06/2026
Web e Social Network
Industria
Scienza
Biotecnologia
Farmaceutica
Salute
Psichiatria
Medicina - Varie
Definium Therapeutics Announces Positive Topline Results from Phase 3 Emerge Study of DT120 Orally Disintegrating Tablet (ODT) in Major Depressive Disorder
Fonte
Definium Therapeutics, Inc.
Emittente
Business Wire
1.00
0
21/06/2026
Web e Social Network
Industria
Scienza
Biotecnologia
Farmaceutica
Salute
Psichiatria
Medicina - Varie
Definium Therapeutics to Discuss Topline Results from Phase 3 Emerge Study in Major Depressive Disorder on June 22, 2026
Fonte
Definium Therapeutics, Inc.
Emittente
Business Wire
1.00
0
15/06/2026
Mercato azionario
Psichiatria
Scienza
Medicina - Varie
Biotecnologia
Salute
Farmaceutica
Definium Therapeutics Announces New Employee Inducement Grants
Fonte
Definium Therapeutics, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0